Rapamycin circumvents anti PD-1 therapy resistance in colorectal cancer by reducing PD-L1 expression and optimizing the tumor microenvironment
Open Access
- 14 June 2024
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 176, 116883
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China-Guangdong Joint Fund
- Guilin Medical University (2024SRP104)
- Natural Science Foundation of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province (2024A03J0189)
- Basic and Applied Basic Research Foundation of Guangdong Province (2024A06J0188)
- Basic and Applied Basic Research Foundation of Guangdong Province (2024A03J0188)
This publication has 51 references indexed in Scilit:
- Multi-targeting liposomal codelivery of cisplatin and rapamycin inhibits pancreatic cancer growth and metastasis through stromal modulationInternational Journal of Pharmaceutics, 2023
- Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142Annals of Oncology, 2022
- A review of the sensitivity of metastatic colorectal cancer patients with deficient mismatch repair to standard-of-care chemotherapy and monoclonal antibodies, with recommendations for future researchCancer Treatment Reviews, 2021
- Dual‐Locking Nanoparticles Disrupt the PD‐1/PD‐L1 Pathway for Efficient Cancer ImmunotherapyAdvanced Materials, 2019
- Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid TumorsCancer Cell, 2019
- Translational repression of Ccl5 and Cxcl10 by 4E‐BP1 and 4E‐BP2 restrains the ability of mouse macrophages to induce migration of activated T cellsEuropean Journal of Immunology, 2019
- Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and MemoryCell, 2019
- Immunomodulators targeting the PD‐1/PD‐L1 protein‐protein interaction: From antibodies to small moleculesMedicinal Research Reviews, 2018
- Rapamycin: One Drug, Many EffectsCell Metabolism, 2014
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010